Exclusive extracts from this 25-page-long report:
- Who is the player?
Johnson & Johnson is leading company in the health care sector with global operations. Its activities are divided into three reporting segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment provides consumer health products (e.g. baby care, oral care, beauty, over-the-counter), while Medical Devices specializes in a range of medical products (e.g. vision, surgery, orthopedics). [...]
- What are the player's strategies?
To further strengthen its Beauty offering, the company has most recently announced the completion of the acquisition of Japanese skincare and cosmetics specialist Ci:z. The move will have a particular impact on J&J sales in Japan and the wider Asia-Pacific region and is a key example of J&J's strategic push to deliver “locally relevant products” across international markets. […]
- What are the player's strengths and weaknesses?
Wide-ranging and diversified healthcare portfolio […]
Historical player enjoying strong brand recognition worldwide […]
High dependence on its home market, the US […]
Loss of patent exclusivity for a number of its blockbuster products […]
- What is the player's financial position?
The financial indicators presented in the report include: Consolidated net revenues, Consolidated operating income and margin, Consolidated net profit and margin, R&D spending and ratio, Sales by segment, Sales performance by segment, Sales by region, Sales performance by region, Profitability ratios, Liquidity ratios, Solvency ratios and Free cash flow and capital expenditure.